Mimicking the evolution of doxorubicin resistance in triple negative breast cancer

被引：0
作者：
Pearson, Kashenya
Everett, Terrence
Rorie, Checo J.
机构：
来源：
CANCER RESEARCH | 2022年 / 82卷 / 10期
关键词：
D O I：
10.1158/1538-7445.EVODYN22-B030
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
B030
引用
收藏
页数：2
相关论文
共 50 条
  • [31] A Predictive Mathematical Modeling Approach for the Study of Doxorubicin Treatment in Triple Negative Breast Cancer
    Matthew T. McKenna
    Jared A. Weis
    Stephanie L. Barnes
    Darren R. Tyson
    Michael I. Miga
    Vito Quaranta
    Thomas E. Yankeelov
    Scientific Reports, 7
  • [32] Combination strategies to overcome doxorubicin induced senescence in triple-negative breast cancer
    Schreiber, Anna R.
    Smoots, Stephen
    Yacob, Betelehem W.
    Dominguez, Adrian T. A.
    Levandowski, Cecilia
    Diamond, Jennifer R.
    Pitts, Todd M.
    CANCER RESEARCH, 2022, 82 (12)
  • [33] Pharmacometabolomics reveals urinary diacetylspermine as a biomarker of doxorubicin effectiveness in triple negative breast cancer
    Thomas J. Velenosi
    Kristopher W. Krausz
    Keisuke Hamada
    Tiffany H. Dorsey
    Stefan Ambs
    Shogo Takahashi
    Frank J. Gonzalez
    npj Precision Oncology, 6
  • [34] Evaluation of the Effect of Taurine and Doxorubicin Combination on Apoptosis and Metastasis in Triple Negative Breast Cancer
    Gedikli, Esra
    Dincsoy, Adnan Berk
    Erdem, Ilker Levent
    Karakoc, Elif
    Muftuoglu, Sevda
    Erdem, Aysen
    ACTA PHYSIOLOGICA, 2023, 240 : 67 - 68
  • [35] Peptide-doxorubicin conjugate for specific uptake by triple negative breast cancer cells
    Ziaei, Elmira
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2019, 258
  • [36] Enhancement of Doxorubicin Efficacy by Bacopaside II in Triple-Negative Breast Cancer Cells
    Rad, Sima Kianpour
    Yeo, Kenny K. L.
    Li, Runhao
    Wu, Fangmeinuo
    Liu, Saifei
    Nourmohammadi, Saeed
    Murphy, William M.
    Tomita, Yoko
    Price, Timothy J.
    Ingman, Wendy V.
    Townsend, Amanda R.
    Smith, Eric
    BIOMOLECULES, 2025, 15 (01)
  • [37] A Predictive Mathematical Modeling Approach for the Study of Doxorubicin Treatment in Triple Negative Breast Cancer
    McKenna, Matthew T.
    Weis, Jared A.
    Barnes, Stephanie L.
    Tyson, Darren R.
    Miga, Michael I.
    Quaranta, Vito
    Yankeelov, Thomas E.
    SCIENTIFIC REPORTS, 2017, 7
  • [38] Triple negative breast cancer
    Ressler S.
    Mlineritsch B.
    Greil R.
    memo - Magazine of European Medical Oncology, 2010, 3 (4) : 185 - 189
  • [39] Pharmacometabolomics reveals urinary diacetylspermine as a biomarker of doxorubicin effectiveness in triple negative breast cancer
    Velenosi, Thomas J.
    Krausz, Kristopher W.
    Hamada, Keisuke
    Dorsey, Tiffany H.
    Ambs, Stefan
    Takahashi, Shogo
    Gonzalez, Frank J.
    NPJ PRECISION ONCOLOGY, 2022, 6 (01)
  • [40] Doxorubicin Conjugation to Reovirus Improves Oncolytic Efficacy in Triple-Negative Breast Cancer
    Berry, Jameson T. L.
    Munoz, Luis E.
    Stewart, Roxana M. Rodriguez
    Selvaraj, Periasamy
    Mainou, Bernardo A.
    MOLECULAR THERAPY-ONCOLYTICS, 2020, 18 : 556 - 572
12345